SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-216814
Filing Date
2019-08-08
Accepted
2019-08-08 16:05:32
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788746d8k.htm 8-K 19046
2 EX-99.1 d788746dex991.htm EX-99.1 57544
3 GRAPHIC g788746dsp005.jpg GRAPHIC 4092
  Complete submission text file 0001193125-19-216814.txt   83604
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 191009490
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1